Investigating Fumarate Hydratase-Deficient Uterine Fibroids: A Case Series.

Uterine leiomyomas or uterine fibroids are the most common benign soft tissue tumor in reproductive-aged women. Fumarate hydratase deficient (FH-d) uterine fibroids are a rare subtype that is diagnosed only on pathologic evaluation. FH-d uterine fibroids may be the first indicator of hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. Therefore, identifying and understanding the clinical implication and diagnosis of FH-d uterine fibroids is critical for early diagnosis of HLRCC. This case series investigates the uncommon yet significant condition of FH-d uterine fibroids. We examined the clinical manifestation, diagnostic imaging, and histopathological characteristics of FH-d uterine fibroids in five cases identified at our institution over the last ten years. All diagnoses were confirmed by pathologic evaluation after surgical treatment. Gynecologists and pathologists play a critical role in the early diagnosis of FH-d uterine fibroids and must recognize the relevant clinical and pathologic findings that raise suspicion about this diagnosis. The detection of these cases is largely dependent on the pathologist's ability to recognize unique histopathologic features. Once these characteristics are identified, it should prompt a referral to a gynecologist to consider conducting germline genetic testing. The management of FH-d uterine fibroids necessitates a multidisciplinary approach, including proper genetic screening and regular surveillance, especially for renal tumors.

[1]  J. Petrozza,et al.  How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase , 2021, F&S reports.

[2]  L. Ousager,et al.  Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review , 2021, Orphanet Journal of Rare Diseases.

[3]  J. Wohlschlegel,et al.  Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction , 2018, Cancer science.

[4]  R. Butzow,et al.  Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases , 2016, The American journal of surgical pathology.

[5]  T. Dwight,et al.  Fumarate Hydratase–deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings , 2016, The American journal of surgical pathology.

[6]  W. Linehan,et al.  Hereditary leiomyomatosis and renal cell carcinoma , 2014, International journal of nephrology and renovascular disease.

[7]  K. Kavanagh,et al.  Structural basis of fumarate hydratase deficiency , 2011, Journal of Inherited Metabolic Disease.

[8]  W. Linehan,et al.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. , 2008, Archives of dermatology.

[9]  Mark Payson,et al.  Epidemiology of myomas. , 2006, Obstetrics and gynecology clinics of North America.

[10]  P. Choyke,et al.  Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. , 2003, American journal of human genetics.